Abstract
AZITHROMYCIN INDUCED URTICARIA REACTION: A RARE CASE REPORT

Bushrah Anjum B.*, Roshan Jameer B., Siddarama.R, Sravanthi D., Asif S. K., Ganesh Reddy V.,
Parveen S.

ABSTRACT

Azithromycin is a mostly preferable antibiotics is effective against a wide assortment of bacteria organisms, such as Hemophilus influenza, Mycoplasma pneumonia, Streptococcus pneumoniae, mycobacterium avium, and Staphylococcus aureus. Which is commonly used antibiotic in patients with various infections like pain during urinating or having sex, unusual vaginal discharge bleeding between periods, pain of below belly button and unusual lumps, bumps, blisters or sores around the genital or anal area. Hypersensitive reactions subsequent azithromycin therapy is unusual but is potentially life-threatening. It is rapidly occurring reactions, hence called immediate hypersensitivity reactions. Whenever the patient exposure to certain drugs (penicillin, cephalosporin's and aspirin) production of IgE antibodies – fix to mast cells then again re-exposure to the same drug antigen-antibody reaction occurs on the mast cell surface then release of inflammatory mediators like histamine, 5-HT, PGs, LTs, PAF these mediators cause the hypotension, bronchospasm, angioedema, urticarial, rhinitis and anaphylactic shock. The management of hypersensitivity (urticaria) reactions. This can manage to stop the drug and by providing symptomatic treatment like anti histaminic therapy and antibiotics.

Keywords: Azithromycine, urticaria, adverse drug reaction, hyper sensitivity reaction.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2023 Issue has been successfully launched on 1 FEBRUARY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT